Skip to content
Preprint

TopoLIA: Topology-Inspired Latent Interaction Attention for Drug Discovery

Oct 2026 · 0 citations · 62 references
Biology

TL;DR

TopoLIA is introduced, a topology-inspired latent interaction attention mechanism that learns not only how much information should be exchanged between interaction partners, but also how that information should be transformed.

Abstract

The growing sophistication of drug discovery calls for new advances in artificial intelligence (AI). Transformers have underpinned recent breakthroughs in AI, yet their conventional source-target attention mechanism can become a bottleneck for modeling complex interactions. Here, we introduce TopoLIA, a topology-inspired latent interaction attention mechanism that learns not only how much information should be exchanged between interaction partners, but also how that information should be transformed. Source-target-dependent attention is mediated through a compact latent interaction space, providing a structured representation of complex interactions. We further incorporate topological spectral representations to capture multiscale data geometry and extract algebraic relationships. TopoLIA thus incorporates topological principles into both data representation and neural network architecture. We demonstrate TopoLIA on protein-ligand binding, where persistent spectra encode multiscale topological and geometric patterns in 3D protein-ligand complexes, while latent interaction attention (LIA) enables structured, source-target-dependent information exchange. We pretrain TopoLIA by reconstructing masked multiscale spectral tokens from unlabeled molecular structures, yielding transferable structural representations without task-specific annotations. Across multiple scoring and docking benchmarks, TopoLIA achieves state-of-the-art performance and consistently outperforms its standard-attention counterpart. Rank analyses show that compact latent dimensions yield the best performance, supporting compact interaction spaces as an effective inductive bias for biomolecular learning. More broadly, LIA provides a general framework for structured, source-target-dependent information exchange that is applicable to diverse scientific and AI problems involving complex heterogeneous interactions.

View source

Similar papers

MAGNN-DTA: Cross-Modal Mutual Attention Graph Neural Networks for Drug-Target Affinity Prediction

The proposed MAGNN-DTA employs a cross-modal mutual attention module to explicitly capture bidirectional interactions between drug and protein modalities, enabling precise identification of key functional groups in drugs and critical binding residues in proteins.

Yun Zhou, Yi-Bo Zhang, Dong Liu et al. · 0 citations
Open access Oct 2026

MEGH-DDI: MolT5-driven edge-aware graph learning with Hop2Token representation for drug-drug interaction prediction.

Drug-drug interactions (DDIs) are critical in pharmacology, as synergistic or antagonistic effects between co-administered drugs can enhance therapeutic outcomes or cause toxicity, posing major challenges for drug safety assessment and new drug development. Current molecular representation methods often fail to capture...

Li Zhou, Yun Zuo, Wen-Ying He et al. · 0 citations
Sep 2026

FGMDTI: Fine-grained Multimodal Learning for Drug-Target Interaction Prediction via Bidirectional Cross-Attention.

Drug-target interaction (DTI) prediction is critical for drug discovery and repositioning. Existing methods often rely on coarse-grained representations and fail to capture the reciprocal nature of molecular recognition. We propose FGMDTI, a fine-grained multimodal framework that models bidirectional interactions betwe...

Meng-De Li, Chi Zhou, Wen-Bin Liu et al. · 0 citations
Open access Aug 2026

Chemi-Proteome Language Attention Network Empowers Fragment-Based Ligand Interactome and Binding Sites Discovery with Evidence

By learning directly from cellular chemoproteomics, C-PLANK moves beyond isolated interaction prediction toward cellular interaction-state modelling, establishing a computational foundation for future digital-twin frameworks in drug discovery.

Bing-Song Liao, Ji-Xiao He, Mingzhu Zhao et al. · 0 citations
#artificial intelligence Preprint Sep 2026

ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

Drug-target interaction (DTI) prediction is an important task in AI-driven drug discovery. Although recent biochemical representation learning methods have improved DTI prediction, their passive feature aggregation tends to favor dominant molecular patterns while suppressing weak yet binding-relevant signals, such as f...

Quan Hao, Meng-Yue Fan, Zi-Fan Dong et al. · 0 citations
Sep 2026

LGBind: A structure-guided deep learning framework for accurate prediction of protein-ligand binding sites.

LGBind is introduced, a structure-guided deep learning framework for generalized, ligand-conditioned binding site identification and demonstrates profound robustness and generalization in predicting novel ligand-target interactions, and demonstrates remarkable versatility.

Yun-Feng Li, Xing-Yu Liu, Yi-Jia Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.